Clinical Trial Update: A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating trastuzumab emtansine in combination with atezolizumab or placebo for HER2-positive, PD-L1-positive locally advanced or metastatic brea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Atezolizumab (Tecentriq) (atezolizumab)
• Trastuzumab Emtansine (Kadcyla) (trastuzumab emtansine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Metastatic Breast Cancer | Phase 3 | Status: TERMINATED | Results posted: 2025-08-08